NuCana plc Reports 2024 Financial Results
Ticker: NCNA · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1709626
| Field | Detail |
|---|---|
| Company | Nucana PLC (NCNA) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, annual-report
TL;DR
NuCana plc dropped its 2024 year-end financials on March 20, 2025.
AI Summary
NuCana plc announced its financial results for the year ended December 31, 2024, on March 20, 2025. The company, headquartered in Edinburgh, United Kingdom, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing provides investors with a year-end financial overview of NuCana plc, crucial for understanding the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial results filing and does not contain significant new risk factors.
Key Players & Entities
- NuCana plc (company) — Registrant
- March 20, 2025 (date) — Date of press release
- December 31, 2024 (date) — Fiscal year end
- Edinburgh, United Kingdom (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used here to announce NuCana plc's financial results for the year ended December 31, 2024.
When did NuCana plc issue the press release announcing its financial results?
NuCana plc issued the press release announcing its financial results on March 20, 2025.
What period do the financial results cover?
The financial results announced cover the year ended December 31, 2024.
Where is NuCana plc's principal executive office located?
NuCana plc's principal executive office is located at 3 Lochside Way, Edinburgh EH12 9DT, United Kingdom.
Is NuCana plc required to file annual reports under Form 20-F or Form 40-F?
NuCana plc is indicated to file annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding NuCana plc (NCNA).